002644 logo

LanZhou Foci Pharmaceutical Co.,Ltd. Stock Price

SZSE:002644 Community·CN¥4.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002644 Share Price Performance

CN¥8.22
0.43 (5.52%)
CN¥8.22
0.43 (5.52%)
Price CN¥8.22

002644 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

2 Risks
1 Reward

LanZhou Foci Pharmaceutical Co.,Ltd. Key Details

CN¥915.5m

Revenue

CN¥606.7m

Cost of Revenue

CN¥308.8m

Gross Profit

CN¥259.6m

Other Expenses

CN¥49.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 30, 2026
0.096
33.73%
5.37%
2.3%
View Full Analysis

About 002644

Founded
1929
Employees
1332
CEO
n/a
WebsiteView website
www.fczy.com

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testing services; and production and sales of medical devices. The company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.

Recent 002644 News & Updates

Recent updates

No updates